Literature DB >> 14697778

Synthesis and evaluation of N1/C4-substituted beta-lactams as PPE and HLE inhibitors.

Stéphane Gérard1, Moreno Galleni, Georges Dive, Jacqueline Marchand-Brynaert.   

Abstract

4-(Alkylamino)carbonyl-1-(alkoxy)carbonyl-2-azetidinones (9-11) have been prepared in five steps from 4-(benzyloxy)carbonyl-1-(t-butyldimethyl)silyl-2-azetidinone (1). The beta-lactam reactivity of 9 has been established by 1H NMR experiment. Compound 11 was a good reversible inhibitor of PPE and HLE. Based on theoretical design, series of 2-azetidinones (12-17) and 4-(alkoxy)carbonyl-2-azetidinones (18-21) bearing various carbonyl (ester, thiolester, amide) and thiocarbonyl (thioamide) functionalities at position N1 were similarly prepared. In the absence of C4-substituent, the compounds were inactive against elastases. On the other hand, 4-(benzyloxy)carbonyl-1-(ethylthioxy)carbonyl-2-azetidinone (19) and 4-(benzyloxy)carbonyl-1-(benzylamino)thiocarbonyl-2-azetidinone (21) were both good reversible inhibitors, but acting most probably via different mechanisms (enzymic processing of the exocyclic ester function or beta-lactam ring opening).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14697778     DOI: 10.1016/j.bmc.2003.10.009

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  3 in total

1.  Synthesis of novel N-sulfonyl monocyclic beta-lactams as potential antibacterial agents.

Authors:  Aliasghar Jarrahpour; Maaroof Zarei
Journal:  Molecules       Date:  2006-01-31       Impact factor: 4.411

2.  Synthesis and antimicrobial activities of some novel diastereoselective monocyclic cis-β-lactams using 2-ethoxy carbonyl DCPN as a carboxylic acid activator.

Authors:  Mahesh Kumar Mishra; Vedeshwar Narayan Singh; Khursheed Ahmad; Sitaram Sharma
Journal:  Mol Divers       Date:  2020-05-13       Impact factor: 2.943

3.  Crystal structure of 1-(4-meth-oxy-phen-yl)-4-(4-nitro-phen-yl)-3-phen-oxy-azetidin-2-one.

Authors:  Sevim Türktekin Çelikesir; Mehmet Akkurt; Aliasghar Jarrahpour; Habib Allah Shafie; Ömer Çelik
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-01-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.